Methods and compositions for inducing apoptosis in cancer cells with an anti-DR5 antibody
US8173128B2 · kind B2 · utility
2Cited by
4References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2006 |
| Grant date | May 8, 2012 |
| Priority date | — |
| Expiry date | Mar 29, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-DR5 antibody agonists, combined with apoptosis-inducing agents, synergistically induce apoptosis in cancer cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.